Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K
Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Clinicopathological, Molecular and DNA Methylation Analysis of Ossifying Fibromyxoid Tumors Delineates the ZC3H7B::BCOR Subset as a Distinct Entity.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune Architecture.

Cancer discovery·2026
Same author

Pitfalls in diagnosis of metatypical adenoid cystic carcinoma.

Histopathology·2026
Same author

Tumoural emboli syndromes case series: diagnostic dilemma in patients with cancer and pulmonary hypertension.

European heart journal. Case reports·2026
Same author

Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of bone.

Frontiers in oncology·2026
Same author

Ossifying spindled and epithelioid tumour: Expanding the clinical and morphologic spectrum of a recently described entity.

Histopathology·2026
Same journal

Update on the molecular pathology of the distinctive giant cell, fibro-osseous and bone forming lesions of the jaws.

Seminars in diagnostic pathology·2026
Same journal

Update on the molecular pathology and classification of odontogenic cysts and tumours.

Seminars in diagnostic pathology·2026
Same journal

MDM2 gene amplification in surgical pathology: biology, diagnostic utility, and clinical relevance in the modern era.

Seminars in diagnostic pathology·2026
Same journal

When three negatives equal a positive: Molecular updates of triple-negative breast carcinomas with favorable prognoses.

Seminars in diagnostic pathology·2026
Same journal

Old school, new insight: Revisiting histomorphology in the modern era of prostate cancer risk stratification.

Seminars in diagnostic pathology·2026
Same journal

Recent advances in genetic predisposition to primary testicular tumors.

Seminars in diagnostic pathology·2026
查看所有相关文章

相关实验视频

Updated: Sep 17, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.7K

这是一个NUT重排的肉瘤.

Sintawat Wangsiricharoen1, Jeanne M Meis2, Wendong Yu2

  • 1Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR 97239, USA.

Seminars in diagnostic pathology
|July 3, 2025
PubMed
概括
此摘要是机器生成的。

纽特重排的肉瘤是一种独特的软组织癌症,由纽特基因重排定义. 它不同于NUT癌,可能对BET抑制剂治疗没有反应.

关键词:
在MGAGA中,MGA是MGA.在MXD1中,MXD1是MXD1.在MXD4中使用.在MXI1中,MXI1是MXI1.现在的NUTM1就是NUTM1.在NUTM2中,这种类型的肉瘤是sarcoma.

更多相关视频

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.8K

相关实验视频

Last Updated: Sep 17, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.7K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.8K

科学领域:

  • 在瘤学瘤学.
  • 病理学 病理学 病理学
  • 遗传学 是一个遗传学.

背景情况:

  • 核突重排肉瘤是软组织肉瘤中的一个新兴实体.
  • 它的特征是特定的NUT基因重组,与NUT癌症不同.
  • 这些瘤表现出多样化的组织学模式,并影响身体的不同部位和年龄组.

研究的目的:

  • 为了定义NUT重排的肉瘤的独特临床病理特征.
  • 为了区分NUT重排的肉瘤和NUT癌瘤.
  • 基于分子特征来探索潜在的治疗影响.

主要方法:

  • 瘤样本的组织病理学分析.
  • 针对NUT和其他标记物的免疫组织化学染色.
  • 分子遗传分析以确定基因重组,特别是涉及MAD转录家族.

主要成果:

  • 存在各种生长模式的NUT重排的瘤 (纤维瘤,圆细胞,上皮状/状,化/嵌套).
  • 瘤细胞通常表达NUT,除了NUTM2重新排列的情况下.
  • 分子分析经常涉及MAD转录家族中的基因.

结论:

  • NUT重排的肉瘤代表了一种独特的肉瘤亚型,具有独特的组织学和分子特征.
  • 它与NUT癌症显著不同.
  • 在NUT癌症中有效的BET抑制剂的疗效可能在NUT重组的肉瘤中受到限制,这表明不同的治疗策略.